Clinical Trials Logo

Filter by:
NCT ID: NCT03605082 Completed - Clinical trials for Healthy Japanese Volunteers

A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects

Start date: July 25, 2018
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability and serum Pharmacokinetics (PK) of single doses of UCB0107 administered in healthy Japanese subjects.

NCT ID: NCT03603678 Completed - Clinical trials for Sleep Apnea, Obstructive

Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor

SANDMAN
Start date: August 13, 2018
Phase: Phase 2
Study type: Interventional

The aim of this study in subjects with obstructive sleep apnea is to investigate pharmacodynamics, safety and tolerability after a single nasal administration of BAY2253651 and to evaluate first safety and tolerability of multiple dosing over 5 consecutive nights in OSA patients.

NCT ID: NCT03603314 Completed - Clinical trials for Severe Sudden Sensorineural Hearing Loss

Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss

AUDIBLE-S
Start date: February 15, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

Primary objective of the study is to assess the efficacy of SENS-401 on hearing loss in comparison to placebo at the end of the 4-week treatment period

NCT ID: NCT03602937 Completed - Clinical trials for Chronic Kidney Diseases

Evaluation of Renastep

Renastep
Start date: April 17, 2018
Phase: N/A
Study type: Interventional

Evaluation of Renastep is a 28-day long, prospective nutritional study that will recruit 15 patients aged between 3 and 18 years of age with Chronic Kidney Disease. Participants will incorporate Renastep into their renal specific diet, during which time they will record gastrointestinal symptoms, adherence to recommended intakes and thoughts on its palatability. A Baseline CRF completed by the Investigator at the start of the trial will record demographic information, GI history and the most recent renal bio-marker results. Bio-marker results recorded as part of routine care over the course of the study will be captured in the End of Study CRF. The study is designed to generate acceptability data that will be used to support an application to the Advisory Committee on Borderline Substances for Renastep to be reimbursable on prescription within the NHS.

NCT ID: NCT03602560 Completed - Clinical trials for Primary Biliary Cholangitis

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

A 52-week, placebo-controlled, randomized, Phase 3 study to evaluate the safety and efficacy of seladelpar in subjects with primary biliary cholangitis (PBC) and an inadequate response to or intolerance to ursodeoxycholic acid (UDCA) The participants might enter the ongoing open-label safety study (NCT03301506) following this double-blind study.

NCT ID: NCT03602339 Completed - Clinical trials for Magnetic Resonance Imaging

Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose

LEADER 75
Start date: November 14, 2018
Phase: Phase 4
Study type: Interventional

The study was conducted to gain knowledge about a new dose of a diagnostic drug that is used for contrast-enhanced Magnetic Resonance Imaging (MRI) of the human central nervous system (CNS). MRI can visualize the anatomy of the body and is used to detect medical conditions. Diagnostic drugs like gadobutrol and gadoterate contain an element called gadolinium that is applied to improve the analysability of MRI-images. The purpose of this study was to examine if contrast-enhanced MRI using a reduced dose of the gadolinium-based contrast agent gadobutrol delivers images of similar quality to those obtained when a full dose of the gadolinium-based contrast agent gadoterate was used.

NCT ID: NCT03602001 Completed - Clinical trials for Overweight and Obesity

Attentive Eating for Weight Loss

Start date: September 7, 2017
Phase: N/A
Study type: Interventional

This trial examined whether a smartphone application designed to encourage a more attentive eating style could help people to lose weight, compared to a control group.

NCT ID: NCT03601650 Completed - Diet Modification Clinical Trials

The Effect of Mindful Eating on Calorie Intake and Diet

Start date: January 21, 2017
Phase: N/A
Study type: Interventional

The study will examine the effect of focussing on the sensory properties of food whilst eating. It will look at effects on calorie intake and diet over a 3-day period among women of a healthy weight. Participants asked to focus on the sensory properties of their food will be compared with a second group of participants who will be asked to eat their food without distractions and a third group who will not be provided with any strategy.

NCT ID: NCT03601559 Completed - Cognitive Change Clinical Trials

The Cognitive Effects of 6 Weeks Administration With a Probiotic

Start date: August 31, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the cognitive and mood effects of a probiotic dietary supplement when taken daily for 42 days in healthy older adults aged 65+

NCT ID: NCT03599687 Completed - Vomiting Clinical Trials

Soiled Airway Tracheal Intubation and the Effectiveness of Decontamination by Paramedics

SATIATED
Start date: July 16, 2018
Phase:
Study type: Observational

In more than one-in-five cases of out-of-hospital cardiac arrest, airways are blocked by vomit and blood. Sometimes, paramedics cannot clear the airway using methods they have been taught. If the airway cannot be cleared, the patient will die. Usually, these patients will have a breathing tube placed into their windpipe (intubation), as this provides protection from vomit and blood. To do this, the paramedic needs to be able to see the entrance to the windpipe. A new method of clearing the airway called SALAD has been used in patients to help insert a breathing tube, but it is not known whether the method can help paramedics. This study will use a manikin to see if paramedics can insert a breathing tube more often on their first attempt, using SALAD.